Literature DB >> 10469895

The chemistry of the metabolites of cyclophosphamide.

S M Ludeman1.   

Abstract

This is primarily an overview of the spontaneous (non-enzymatic) chemistry of the metabolites of cyclophosphamide, viz., cis- and trans-4-hydroxycyclophosphamide, aldophosphamide (and its hydrate), iminophosphamide, phosphoramide mustard, acrolein, and chloroethylaziridine. A brief description of detoxification products obtained through enzyme catalyzed reactions appears. Included as the historical basis for the development of cyclophosphamide is the chemistry of nitrogen mustards. Among the topics covered are: perturbations to metabolite distributions and half-lives effected by buffer, structure, pH and nucleophiles; effects of pH on mechanism; alkylation versus P-N bond hydrolysis; the influence of nucleophiles on alkylation product distributions; the influence of substituents on alkylation rates; and preactivated forms of cyclophosphamide as metabolite precursors (4-hydroperoxycyclophosphamide and mafosfamide). A review with 66 references.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469895

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  41 in total

Review 1.  Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity.

Authors:  Poulomi Bhattacharya; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-13       Impact factor: 4.219

2.  Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.

Authors:  Yi Luan; Maxwell E Edmonds; Teresa K Woodruff; So-Youn Kim
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

3.  Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.

Authors:  Benigno C Valdez; Moustapha Hassan; Borje S Andersson
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

4.  Cyclophosphamide has Long-Term Effects on Proliferation in Olfactory Epithelia.

Authors:  Nora Awadallah; Kara Proctor; Kyle B Joseph; Eugene R Delay; Rona J Delay
Journal:  Chem Senses       Date:  2020-03-25       Impact factor: 3.160

5.  A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Authors:  Adam C Palmer; Christopher Chidley; Peter K Sorger
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

6.  Vanadium as a chemoprotectant: effect of vanadium(III)-L-cysteine complex against cyclophosphamide-induced hepatotoxicity and genotoxicity in Swiss albino mice.

Authors:  Abhishek Basu; Arin Bhattacharjee; Somnath Singha Roy; Prosenjit Ghosh; Pramita Chakraborty; Ila Das; Sudin Bhattacharya
Journal:  J Biol Inorg Chem       Date:  2014-04-29       Impact factor: 3.358

7.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

Review 8.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

9.  Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.

Authors:  Ryan J Hansen; Susan M Ludeman; Sari J Paikoff; Anthony E Pegg; M Eileen Dolan
Journal:  DNA Repair (Amst)       Date:  2007-05-07

10.  Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells.

Authors:  Concepcion Conejero-Goldberg; Kirk Townsend; Peter Davies
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.